Clinical Trials Browser

Phase 1 × Unknown × Rituximab × Clear all

NCT06164327 2023-12-11

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Unknown

75 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05379647 2022-05-18

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

Phase 1 Unknown

24 enrolled

Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

NCT01619761 2020-02-11

NK Cells in Cord Blood Transplantation

Phase 1 Unknown

13 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01439750 2017-08-07

Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)

Phase 1 Unknown

13 enrolled

Lymphoid

Lymphoma, Lymphoma, Mantle-Cell